v3.26.1
SCHEDULE OF BRIAPRO RESTRICTED STOCK UNITS GRANTED (Details) - Restricted Stock Units (RSUs) [Member]
 9 Months Ended
Apr. 30, 2026
USD ($)
shares
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Number of RSU's outstanding, beginning balance | shares
Aggregate intrinsic value, beginning balance | $
Number of RSU's outstanding, granted | shares 40,000 [1]
Aggregate intrinsic value, granted | $ $ 376,000 [1]
Number of RSU's outstanding, ending balance | shares 40,000
Aggregate intrinsic value, ending balance | $ $ 167,200
BriaPro Therapeutics Corp, [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Number of RSU's outstanding, beginning balance | shares 19,200
Aggregate intrinsic value, beginning balance | $ $ 700
Number of RSU's outstanding, granted | shares 7,189,000 [2]
Aggregate intrinsic value, granted | $ $ 262,399 [2]
Number of RSU's outstanding, ending balance | shares 7,208,200
Aggregate intrinsic value, ending balance | $ $ 263,099
[1] On September 24, 2025, the Company granted 40,000 RSUs to directors under the Omnibus Plan. These RSUs vest in full on the earlier of September 23, 2028 or the occurrence of a change of control, resignation, or dismissal without cause. The grant-date fair value of these RSUs was $376,000.
[2] On April 1, 2026, BriaPro granted 7,189,000 RSUs to directors under the Omnibus Plan. These RSUs vest in full on April 1, 2027. The grant-date fair value of these RSUs was $262,399, based on a grant-date fair value of $0.0365 per RSU.